Molecular research is expensive, but worth it because of the burden of disease that it could relieve.
Academic rigor, journalistic flair
Articles on Neglected Tropical Diseases
Displaying 1 - 20 of 23 articles
Progress against neglected tropical diseases is now at real risk of reversal as a result of the COVID-19 pandemic.
Relying on donor funding means that the funder ultimately determines the health priorities. This is one reason why many programmes in Africa focus on a single disease such as HIV.
Many of these diseases cause tremendous suffering and death – yet there’s still a lack of effective tools to diagnose, treat, and prevent them.
Every year, around 455 million get scabies. Not that you’d know, because no one talks about it.
Schistosome worms infect hundreds of millions of people worldwide. Researchers have discovered how to use inexpensive drones to identify disease hotspots in remote African villages.
There’s a big market for new treatments for TB, malaria and other ailments. But most of these diseases afflict low-income people unable to pay for medicine.
Scientists need to continue working across disciplines to find ways to disrupt disease transmission in the context of climate change.
A cure for many tropical diseases was discovered 30 years ago this month. The drug is donated by its manufacturer. Why are we still dealing with neglected tropical diseases?
How will the World Health Organisation’s Director-General Dr Tedros Ghebreyesus deal with the mounting challenges? Africa’s academics have some tips.
Scabies was one of the scourges of those on the First Fleet, but no longer known for most in Australian society. However, in the far remote North, scabies infection is endemic.
There’s a growing body of evidence that shows we could be doing more for the close to billion children at risk of intestinal worms. We simply cannot afford to ignore it.
Although a drug of known safety and efficacy is available, scabies still affects more than 100 million people across the world.
A century and a half after buruli ulcer was discovered, the disease continues to mystify scientists.
Although there have been global efforts to eliminate parasites, some parasites and vectors will have survived attack because they have evolved resistance.
The collapse of Syria’s health system is helping spread leishmaniasis but not in the way some media outlets have reported.
The drug that led to two scientists wining the Nobel Prize for Physiology or medicine has made a significant difference for those suffering from elephantiasis and river blindness.
Health has secured its place as one of the 17 Sustainable Development Goals. But without clear mechanisms to report, finance or engage other sectors, could more end up as less?
This parasitic infection is endemic in Central and South America, and can lead to serious health complications. Though rare in the US, incidence is starting to increase.
Some experts worry that the Ebola crisis is diverting attention and resources away from neglected diseases with a substantially larger disease incidence.
Top contributors
-
Professor in Global Health Infection and Immunity. and co-Director of the Global Health Academy, University of Edinburgh
-
Senior Staff Specialist, Alice Springs Hospital. Purple House Medical Advisor. Honorary ANU., Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Lecturer in Parasitology and Evolutionary Biology, University of New England
-
PhD Candidate, Zoonotic Infectious Diseases, McGill University
-
President of the Royal Statistical Society and Professor of Biostatistics, Epidemiology and Population Health, Lancaster University
-
Research Associate Professor, Tufts Center for the Study of Drug Development, Tufts University
-
Assistant Professor-Division of Infectious Diseases, The Ohio State University
-
Senior lecturer, Newcastle University
-
Associate Professor of Global Health Systems, The University of Queensland
-
Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine
-
Professor of Biochemical Parasitology, University of Glasgow
-
Group Leader, Murdoch Childrens Research Institute. Associate Professor, Department of Paediatrics, University of Melbourne. Paediatric Infectious Diseases Physician, Royal Children's Hospital, Murdoch Children's Research Institute
-
Lecturer at the Department of Biochemistry, Cell and Molecular Biology, University of Ghana
-
Division of Family Medicine and Primary Care, Stellenbosch University
